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Abstract  
 
Objective(s) 
To compare two identification methods, i.e., restriction fragment length polymorphism (RFLP)-PCR analysis 
and enzymatic method Rapid TM Yeast Plus System to identify different species causing vulvovaginal 
candidiasis (VVC). 
Materials and Methods 
Vaginal discharges of women who had attended the gynecology outpatient clinic of Mobini Hospital in 
Sabzevar, Iran were collected using cotton swabs and were cultured on Sabouraud dextrose agar. Isolated 
yeasts were identified by germ-tube testing and Rapid TM Yeast Plus System (Remel USA). For molecular 
identification, the isolated DNA was amplified with ITS1 and ITS4 universal primers and PCR products 
digested with the enzyme HpaІІ followed by agarose gel electrophoresis. Epidemiological and clinical 
features of women with respect to identified species were also evaluated. 
Results 
Out of 231 subjects enrolled, 62 VVC cases were detected. The isolated species were identified as follows: 
Candida albicans, 24 (38.7%), C. glabrata, 15 (24.2%), C. kefyr, 13 (21.0%) C. krusei, 9 (14.5%), and 
Saccharomyces cerevisiae, 1 (1.6%) by RFLP-PCR method; whereas findings by Rapid TM Yeast Plus 
System were C. albicans, 24 (38.7%), C. glabrata, 5 (8%), C. kefyr, 11 (17.7%) C. krusei, 2 (3.2%), S. 
cerevisiae, 9 (14.5%), and C. tropicalis, 6 (9.6%) as well as other nonpathogenic yeasts, 4 (6.9%). 
Conclusion 
Statistical comparison showed that there is no significant difference in identification of C. albicans by the 
two methods; although, in this study, it was not true about other species of yeasts. A correlation between 
clinical and laboratory findings is important as it enables us to administer an appropriate treatment on time. 
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Introduction 
Vulvovaginal candidiasis (VVC) is a common 
problem in women and may affect their 
physical and emotional health, as well as 
relationships with their partners (1). 
Candida species causes 20 to 25% of VVC 
cases, whereas 40 to 50% of VVC cases are 
caused by bacteria (2). VVC is characterized 
by pruritus, soreness, changes in discharges, 
dyspareunia, vulvar erythema, edema, and 
fissures (2, 3). The condition is rare before 
puberty but by the age of 25, nearly 50% of all 
women will have had at least one clinician-
diagnosed episode of VVC (4, 5). The 
condition is less common in postmenopausal 
women. Overall, it is estimated that 75% of all 
women experience an episode of VVC in their 
lifetime (2, 6, 7). Candida albicans is 
responsible for 78.75% of all cases of VVC in 
Shiraz, south-west of Iran, (8) and 80 to 92% 
of all cases of VVC worldwide (2). Vaginal 
colonization by non-albicans species is more 
common in immunodeficient women. 
However, an increased frequency of infections 
by non-albicans Candida species, particularly 
C. glabrata, C. parapsilosis, and C. tropicalis 
has been reported in healthy women (9). 
Conventional methods for the identification of 
Candida species are based on assimilation, 
fermentation reactions, and morphology (10, 
11). These techniques are time-consuming and 
their reliance on phenotypic expression makes 
them potentially unreliable. Considering many 
limitations of phenotyping methods for 
vulvovaginal candidiasis, recent advances in 
using molecular DNA analysis have facilitated 
the development of identification systems at 
species level (10-15). Identification of 
Candida species had been achieved by 
restriction fragment length polymorphism 
(RFLP) analysis of the ribosomal DNA 
(rDNA) repeat of Candida species in previous 
studies (10, 12, 16). In the present study, we 
tried to compare conventional methods, i.e., 
enzymatic Rapid TM Yeast Plus System with 
the molecular technique RLFP-PCR. 
 
Materials and Methods 
Having taken written consent, 231 sexually 
active women participated in this consented 
study and were examined according to the 
definition of vulvovaginal candidiasis (severe 
itching and abnormal discharge). All vaginal 
specimens were collected in Mobini hospital in 
Sabzevar, north-east of Iran, between January 
and December 2007. Vaginal discharge was 
sampled with two sterile swabs, one swab used 
for direct examination and 10% KOH and the 
other one for gram stained smears. The smears 
were examined for detecting the presence or 
absence of pseudohyphae and blastoconidia. 
The other swab was applied to culture the 
sample on Sabouraud agar medium and then 
was incubated at 37 ◦C for 72 hr. 
The pH of vaginal secretions was measured 
by color pH indicator sticks (MCLB 
Manufacturing Chemists Inc., Cincinnati, OH) 
applied directly against the lateral vaginal 
wall, avoiding contact with cervical mucus. 
Isolated yeasts were identified based on 
assimilation and fermentation reactions using 
Rapid TM Yeast Plus System (Remel USA) 
morphology and germ-tube testing. 
Genomic DNA of each individual fresh 
colony was extracted and purified using glass 
bead disruption as described by Mirhendi et al 
(17). Molecular identification was carried out 
based on the method described previously 
(18). Briefly, internal transcribed spacer (ITS) 
regions of ribosomal DNA (rDNA) were 
amplified using the universal forward 
(ITS1:5’-TCC GTA GGT GAA CCT GCG G-
3’) and reverse (ITS4: 5’-TCC TCC GCT TAT 
TGA TAT GC-3’) primers. 
For the optimum PCR conditions, a reaction 
volume of 50 µl contained 0.2 mM of each 
deoxynucleoside triphosphate, (dNTP),          
0.5 µM of each primer, 5 µl of 10x PCR buffer 
and 1.25 U of Taq Polymerase (Fermentas, 
Lithuania) and 1 µl of extracted DNA as 
template were used. A negative control 
containing sterile deionized water instead of 
the template DNA was included in each PCR 
run. Reaction mixtures were subjected to an 
initial denaturation step at 94 oC for 5 min  
followed by 30 cycles of the following 
incubations: denaturation at 94 oC for 45 sec, 
annealing at 56 oC for 1 min and extension at 
72 oC for 1 min with a final extension at 72 oC 
for 7 min. A Corrbett research thermal cycler 
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(Australia) was used for the PCR reactions. A 
10 µl aliquot of each PCR product was 
electrophorezed in 1.5% (w/v) agarose gel in 
TBE (90 mM Tris, 90 mM boric acid, 2 mM 
EDTA) buffer and stained with ethidium 
bromide (0.5 µg/ml) and visualized by 
illumination with UV light.  
For RFLP analysis, 21.5 µl aliquots of PCR 
products were digested individually with 10 U 
of restriction enzyme HpaII (Fermentas 
Lithvania) in a final reaction volume of 25 µl 
followed by 2.5 hr incubation at 37 oC. RFLP 
products were analyzed by 2% agarose gel 
electrophoresis in TBE buffer and stained with 
ethidium bromide. 
Pearson Chi-Square test were used to analyze 
differences in discrete variables. Findings were 
considered significant at P< 0.05. 
 
Results 
A total number of 231 women were included 
in this study. The most frequent age interval 
was between 26 and 35 years old, representing 
42% of the total samples. All patients were 
married, most of them were illiterate (n= 88, 
38%) and housewives (n= 222, 96%) and the 
rate of pregnant women was 33 (14.3%). The 
mean pH of vaginal samples was 4.79±1.27. 
   
Direct Examination and Culture 
Sixty two (26.8%) of the women tested positive 
for Candida by culture, of which only 17 (7.4%) 
were positive by wetmount/Gram stain as 
a confirmation for vulvo-vaginitis.  
The highest frequencies were found in women 
between 26 and 35 years, 30 (12.9%) and women 
between 15 and 25 years old, 21 (9.1%) 
respectively (Table 2).  In addition, from the total 
yeasts identified 50% and 7.8% were C. albicans 
for symptomatic and asymptomatic vulvovaginal 
candidiasis respectively. 
Seventeen (51.5%) of the pregnant women 
tested were positive for Candida by culture 
method (Table1). 
 
Enzymatic Rapid TM Yeast Plus System 
By this method, 24 (10.3%) of isolated 
Candida species were identified as C. 
albicans. Other species, 38 (16.4%), were      
C. glabrata, 5 (8%), C. kefyr, 11 (17.7%)       
C. krusei, 2 (3.2%), S. cerevisiæ, 9 (14.5%) C. 
tropicalis, 6 (9.6%), C. regusa, Trichosporon 
bedgli, Blastoschizomyces yesis and C. 
elypolytica each 1 (14.5%), and an unknown 
yeast 1 (14.5%) (Table 3). 
 
RFLP-PCR 
Fungus-specific universal primer pairs (ITS1 
and ITS4) were able to successfully amplify 
the ITS regions of all tested isolates, providing 
a single PCR product of approximately 510- 
870 bp (Figure 1). PCR products which were 
digested with HpaII revealed that the bands 
generated corresponded to the predicated sizes 
(Figure 2). Digestion of the ITS region of 
Candida species by HpaII generated 2 bands 
for C. albicans, C. glabrata, and C. krusei 
(Figure 2).  HpaII was not able to digest the 
ITS regions of C. kefyr and C. parapsilosis. 
They were identified using another molecular 
method (19) (data is not shown).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. An example of ethidium bromide-stained gel 
image. Lanes 1-17 amplified ITS region PCR products 
Lane M: 100 bp ladder molecular size marker. 
Lanes 1, 59, 11 and 15-17, C. albicans; Lanes 2, 7 and 8            
C. kefyr, Lanes 3, 4 and 10 C. glabrata; Lanes 6, 12     
C. krusei; Lanes 13, Saccharomyces cerevisiae. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. An example of PCR-RFLP patterns for Candida 
isolates Lane M: 100 bp ladder molecular size marker; 
lanes 1-18. lanes lanes 1, 2, 16 and -17  C. krusei; Lanes 9, 
11 and 13, C. glabrata; Lanes 3 -5, 7, 8, 10,12,14,15 and 
18, C.albicans; 9;  Lane 6 C. kefyr . 
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Table 1. The distribution of different Candida species according to the demographic characters by RFLP-PCR method 
(F= Frequency, Neg. =Negative). 
 
positive 
F (%) 
Other yeasts  Demographic characterization 
Neg. 
F 
% C. a lbicans C. glabrata C. krusei C. kefyr Saccharomyces cerevisiæ 
Total 
F 
% 
16 (7) 72 
31.1 5 (2.2) 3 (1.3) 5 (2.2) 3 (1.3) 0 (0.0) 
88 
38.1 
46 (20) 
Educational standard 
 
Literate 
 
I lliterate 
97 
41.9 19 (8.2) 12 (5.2) 4 (1.7) 10 (4.3) 1 (0.4) 
143 
61.9 
2 (0.9) 7 
3 0 (0.0) 0 (0.0) 1 (0.4) 1 (0.4) 0 (0.0) 
9 
3.9 
60 (26) 
Occupational 
 
Occupied  
 
housekeeper 
162 
70.1 24 (10.4) 15 (6.5) 8 (3.4) 12 (5.2) 1 (0.4) 
222 
96.1 
16 (7) 17 
7.3 10 (4.3) 4 (1.7) 2 (0.9) 0 (0.0) 0 (0.0) 
33 
14.3 
46 (19.9) 
Pregnancy 
 
Pregnant  
 
Non-pregnant 
152 
65.8 14 (6.1) 11 (4.8) 7 (3.0) 13 (5.6) 1 (0.4) 
198 
85.7 
62 (26.8) Total 169 73.1 24 (10.4) 15 (6.5) 9 (3.9) 13 (5.6) 1 (0.4) 
231 
100 
 
 
 
Table 2. The distribution of different Candida species according to age groups. (F=Frequency, Neg.= Negative). 
 
positive
F (%) 
Other yeasts 
Neg. 
F 
% C. albicans C. glabrata C. krusei C. kefyr Saccharomyces cerevisiae 
Total 
F 
% 
21(9.1) 
10 (4.3) 
46 
19.9 11 (4.8) 5 (2.2) 1 (0.4) 4 (1.7) 0 (0.0) 
57 
24.6 
30 (13) 
22 (9.5) 
67 
29 8 (3.5) 
 10 (4.3) 5 (2.2) 6 (2.6) 1 (0.4) 
97 
42 
9 (4) 47 
20.3 4 (1.7) 0 (0.0) 2 (0.9) 3 (1.3) 0 (0.0) 
 
56 
24.3 
2 (1) 
15 
6.4 1 (0.4) 0 (0.0) 1 (0.4) 0 (0.0) 0 (0.0) 
17 
7.4 
Age groups 
 
 
  
 
 
15-25 
 
  
 
26-35  
 
  
 
36-45  
 
 
46-55 
 
 
 
>55 
4 
1.7 0 (0.0) 
 
4 
1.7 
62 (26.8) Total 169 
73.1 24 (10.4) 
 
15 (6.5) 
 9 (3.9) 13 (5.6) 1 (0.4) 
231 
100 
Comparison of Two Methods for Identification of Yeast 
              Iran J Basic Med Sci, Vol. 14, No. 5, Sep-Oct 2011 447
 
 
To
ta
l 
88
 
(3
8.
1)
 
14
3 
(6
1.
9)
 
9 
(3
.9
) 
22
2 
(9
6.
1)
 
33
 
(1
4.
3)
 
19
8 
(8
5.
7)
 
23
1 
(1
00
) 
10
 
0 1 
(0
.4
) 
1 
(0
.4
) 
0 0 1 
(0
.4
) 
1 
(0
.4
) 
9 0 1 
(0
.4
) 
0 1 
(0
.4
) 
0 1 
(0
.4
) 
1 
(0
.4
) 
8 0 
1 
(0
.4
) 
0 
1 
(0
.4
) 
0 
1 
(0
.4
) 
1 
(0
.4
) 
7 1 
(0
.4
) 
0 0 1 
(0
.4
) 
1 
(0
.4
) 
0 1 
(0
.4
) 
6 3 
(1
.2
) 
8 
(3
.4
) 
0 11
 
(4
.7
) 
0 11
 
(4
.7
) 
11
 
(4
.7
) 
5 1 
(0
.4
) 
8 
(3
.4
) 
0 9 
(3
.8
) 
3 
(1
.2
) 
6 
(2
.5
) 
9 
(3
.8
) 
4 0 1 
(0
.4
) 
0 1 
(0
.4
) 
0 1 
(0
.4
) 
1 
(0
.4
) 
3 1 
(0
.4
) 
1 
(0
.4
) 
0 2 
(0
.8
) 
0 2 
(0
.8
) 
2 
(0
.8
) 
2 
4 
(1
.7
) 
2 
(0
.8
) 
0 
6 
(2
.5
) 
1 
(0
.4
) 
5 
(2
.1
) 
6 
(2
.5
) 
O
th
er
 Y
ea
st
s 
1 
1 
(0
.4
) 
4 
(1
.7
) 
0 
5 
(2
.1
) 
1 
(0
.4
) 
4 
(1
.7
) 
5 
(2
.1
) 
Po
sit
iv
e 
F 
(%
) 
C
. 
al
bi
ca
ns
 
16
 (6
.9
) 
5 
(2
.1
) 
46
 (1
9.
9)
 
19
 (8
.2
) 
2 
(0
.8
) 
1 
(0
.4
) 
60
 (9
.2
5)
 
23
 (9
.9
) 
16
 (6
.9
) 
10
 (4
.3
) 
46
 (1
9.
9)
 
14
 (6
) 
62
 (2
6.
8)
 
24
 (1
0.
3)
 
N
eg
. 
F 
 
(%
) 
72
  
(3
1.
1)
 
97
  
(4
1.
9)
 
7 (3
) 
16
2 
(7
0.
1)
 
17
 
(7
.3
) 
15
2 
(6
5.
8)
 
16
9 
(7
3.
1)
 
D
em
og
ra
ph
ic
 
ch
ar
ac
te
ri
za
tio
n 
Ed
uc
at
io
na
l s
ta
nd
ar
d 
 
Li
te
ra
te
 
   
Ill
ite
ra
te
 
O
cc
up
at
io
na
l 
 
O
cc
up
ie
d 
 
 
ho
us
ek
ee
pe
r 
Pr
eg
na
nc
y 
 
pr
eg
na
nt
 
   
N
on
-p
re
gn
an
t 
To
ta
l 
Ta
bl
e 
3.
 T
he
 d
is
tri
bu
tio
n 
of
 d
iff
er
en
t C
an
di
da
 sp
ec
ie
s a
cc
or
di
ng
 to
 th
e 
de
m
og
ra
ph
ic
 c
ha
ra
ct
er
s b
y 
en
zy
m
at
ic
 m
et
ho
d 
R
ap
ID
 Y
ea
t P
lu
s S
ys
te
m
 (F
- 
Fr
eq
ue
nc
y,
 N
eg
.=
 N
eg
at
iv
e)
. 
1-
 C
. g
la
br
at
a,
 2
- C
.tr
op
ic
al
is 
3-
C
.k
ru
se
i 4
- C
. r
eg
us
a 
5-
 S
. c
er
ev
is
ia
e 
6-
 C
. k
ef
yr
 7
- T
.b
ed
gl
i 8
- B
.c
ap
ita
te
is 
9-
 C
. e
ly
po
ly
tic
a 
10
- a
n 
un
kn
ow
n 
ye
as
t 
Hossein Moallaei et al 
          Iran J Basic Med Sci, Vol. 14, No. 5, Sep-Oct 2011 448
By RFLP-PCR method, C. albicans, 24 
(10.3%), C. glabrata, 15 (6.4%), C. kefyr, 13 
(5.6%), C. krusei, 9 (3.8%), and S. cerevisiae, 
1 (0.4%) were identified as the etiologic agents 
of VVC, respectively in the community (Table 
1 and Table 2). 
 
Discussion 
Traditionally, identification and 
characterization of yeast species and strains 
have been based on morphological traits and 
especially on their physiological abilities. It is 
frequently necessary to conduct approximately 
5-10 tests to identify reliability at the species 
level for most of the yeasts (20-22). In 
contrast, molecular biology techniques provide 
alternative methods and are becoming routine 
tools in the identification of yeasts. RFLP-
PCR is based on the digestion of amplified 
DNA. Every organism possesses unique 
nucleotide sequences that distinguish it from 
every other organism on the basis of the 
number and size of the fragments. DNA is 
extracted from isolates and cleaved into 
fragments by restriction endonucleases and the 
fragments are separated by gel electrophoresis 
(12, 15). RFLP requires no long time and 
work. The method has been used for 
genotyping a variety of pathogens within the 
last few years (15). 
In this study, the frequencies of isolated 
yeasts from VVC were studied by a profile of 
PCR-RFLP previously described by Mirhendi 
and coworkers (19).  
In the present study, the median age of 
women, with positive culture was 29.5±6.5 
and those with negative culture was 33.8±9.8 
and independent samples t-test revealed that 
this differences is significant and the Pearson’s 
Chi-square test showed a significant statistical 
correlation between positive vaginal Candida 
culture, pregnancy and pH of vagina              
(P< 0.005). The overall prevalence of 
vulvovaginal candidiasis in a community 
setting was found to be 26.8%. This was 
higher than Hamadan, northwest of Iran and 
elsewhere (23-25) and lower than Shiraz and 
south of Iran (8). Some previous reports rated 
prevalence between 30 and 50 percent (26). 
However, the overall percentage of non-
albicans vaginitis was 16.4%.  Although this 
data was closed to studies of Spinillo (27), 
who found 17% for the rate of non-albicans 
Candida species, it showed higher rates than 
those in studies of Vabrik and Pauitch. It was 
also lower than those in studies of Pakshir (8), 
Mohanty et al (24), Nyirjesy et al (30), where 
these rates were 21.25, 4.8 and 32%, 
respectively (8). 
Comparison between the molecular and 
enzymatic methods demonstrated that both of 
them have a similar sensitivity to the albicans 
species of Candida; but they are different in 
others. The molecular method as a gold 
standard showed that there might be false 
positive results in identification of non-
albicans species such as C. regusa, T. bedgli, 
B. capitateis, C. elypolytica, C. tropicalis, and 
C. cerviciea, and false negative issues in 
differentiating of species like C. glabrata,         
C. krusi, and C. kefyr. These suggest that 
where identification of yeast species, such as 
antifungal drug administration, is important 
the molecular method is preferred             
(Table 2 and Table 3).   
A postulated risk factor for C. glabrata 
vaginitis is a higher alkaline pH. It also occurred 
in concomitant bacterial vaginitis which was in 
agreement with our findings (31). 
Our results showed that the detection of 
Candida in vaginal swabs is corolated with  
the age of patients. Some previous reports 
were in agreement with our results (2, 4-6). It 
was shown that women under 35 years old            
(Table 2, Group I and II) have the highest rate 
of detectable Candida compared to the other 
groups. This rate was undetectable over the 
age of 55 years (Table 2, Group V). In 
addition, our data showed that Candida 
species had interesting trends to the age of 
patients as the overall detection of Candida 
decreased with age and changed in the 
distribution of individual species. The 
detection rate of non-albicans Candida 
increased 2.75 folds in the age group of 26 to 
35 years (Table 2, Group II). This rate  
decreased 1.25 folds in the age group of 46 to 
55 compared to the positive cases for               
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C. albicans in the age group of 55 to 65 years 
(Table 2, Group III). These results were close 
to those found by Trama et al (32). 
Moreover, the rate of C. glabrata increased 
2folds in the age group of 26 to 35 years 
(Table 2 Group II). It could be postulated that 
these changes in distribution were related to 
selection of resistant species by widespread 
use of azoles-based anti-fungal drugs (33), 
hormonal changes due to menopause and 
estrogen treatments (6, 7), the effects of aging 
on protective immune responses (34, 35), and 
prolonged stays in hospital (33). These factors 
might change the vaginal environment and the 
characteristics of vaginal floral to favor the 
growth and virulence of non-albicans species, 
or be due to increase exposure of subject to 
non-albicans species. 
We observed that the incidence of VVC in 
pregnant women was 3.5 fold higher than that of 
non-pregnant women. It continued to increase in  
the third trimester of pregnancy which was in 
agreement with other study (36). 
Pregnancy has been known to be associated 
with depressed aspects of cell-mediated 
immunity that permit fatal retention. 
Moreover, the hormonal changed milieu of the 
vagina during pregnancy enhances Candida 
colonization and serves as a risk factor for 
symptomatic expression (37). 
 
Conclusion 
According to our findings, RFLP-PCR can be 
used as a gold standard method for 
identification of isolated yeast from 
vulvovaginal candidiasis. Otherwise, the 
enzymatic method RapID Yeast Plus System is 
not capable to identify different yeasts.   
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